Skip to content
Compare prices

Pen and dosing guide

Mounjaro Golden Dose: What It Was and Why the 2026 Pen Removed It

The “golden dose” is the name social media gave to the liquid left in a Mounjaro KwikPen after the four prescribed weekly doses. It was never a fifth dose, and Eli Lilly redesigned the pen in 2026 so that almost nothing is left. This guide explains why the overfill existed, why using it was never recommended, what the new pen looks like, and what to do if you have relied on it.

  • Written by Nick Johnson, Independent Prescription Pricing Analyst
  • Last reviewed 29 August 2026
  • Information, not medical advice

Key facts

  • Every Mounjaro KwikPen is designed and licensed to deliver exactly four doses of one strength. The leaflet tells you to dispose of the pen after the fourth dose, whatever is left inside.
  • The original pen was overfilled to allow for priming before each injection and to guarantee that all four doses were full. The leftover was never a measured amount.
  • On 6 March 2026 Eli Lilly announced a redesigned KwikPen with a lower plunger start position and an extended internal plunger. It began reaching UK pharmacies in April 2026 and leaves almost no residual liquid.
  • The medicine inside is unchanged: same tirzepatide, same strengths from 2.5 mg to 15 mg, same injection technique. Both pen versions may be in circulation while old stock runs down, and either is genuine.
  • If you had been stretching a pen to five weeks, your treatment now costs what a four-dose pen costs. Order your next pen before your fourth injection so there is no gap.

What the golden dose actually was

The KwikPen is a device Lilly originally built for insulin, where a 3 ml cartridge is dialled down in small units. Adapting it for a weekly medicine meant loading enough liquid for four fixed 0.6 ml doses plus the small amount used each time you prime the needle. Fill tolerances added a little more on top. The result was that after four injections a visible amount of liquid remained, sometimes enough that people could dial and inject something close to a fifth dose.

Online, that leftover acquired a nickname and a following. Some people saw it as a free week of treatment; others took it as a sign the pen was under-dosing. Neither was true. It was overfill, and the amount varied from pen to pen.

Why using it was never recommended

Three reasons, none of them moralising:

  • The amount was not guaranteed. The pen mechanism is only tested to deliver four doses accurately. A fifth attempt might deliver a full dose, a partial one or nothing, and you would not know which. An unplanned partial dose does not help weight loss and can muddle the picture when you and your prescriber judge whether a dose step is working.
  • The pen is not designed to be opened. Forcing the lock or drawing the liquid out with a separate syringe risks contamination, injury and a dose you cannot measure. The MHRA also warns that tampered or reassembled pens are a route by which counterfeit medicine circulates.
  • Prescriptions are written for four doses. A five-week gap between pens is a form of self-adjusted dosing that your prescriber has not agreed to and cannot factor into your care.

Monj does not have a view on whether people should or should not have done this. The point is that the manufacturer, the regulator and prescribers all said the same thing, and the pen has now been changed so the question no longer arises.

The 2026 KwikPen redesign

Lilly announced the modified pen on 6 March 2026 and began shipping it to UK wholesalers from April. The changes are mechanical only:

  • The plunger starts further down the cartridge, so the visible pocket of liquid at the top that some people used as a sign of a full pen is smaller or absent.
  • An extended internal plunger component means that after the fourth dose the plunger sits near the end of the cartridge, making it obvious the pen is finished.
  • The Instructions for Use in the box have been updated with new diagrams.

Everything else is the same: strength, colour coding, the dial, priming, the needles, storage and disposal. You do not need a new prescription. If your pharmacy sends the older pen for a while, that is normal and it is still genuine stock. Because both versions look similar, the reliable way to confirm a pen is genuine remains the same as before: buy only from a pharmacy on the GPhC register and check the tamper seal, batch number and expiry on the box.

If you had been relying on it

Be honest with yourself about the practical effect. If a pen used to last you five weeks, the true monthly cost of your treatment has just gone up by a quarter, and it is worth re-checking whether your current pharmacy is still the best value at your dose. The Monj price comparison ranks every verified UK pharmacy by total cost including delivery, and the discount price list shows the same with current codes applied.

Second, set a reminder to reorder before your fourth injection rather than after. Most online pharmacies dispatch within one to three working days and many close over weekends, so ordering on the day of your last dose can leave a gap. Our guide to running out between pens covers the missed-dose rules and what to do if a delivery is late.

Common questions

My new pen has no liquid visible at the top. Is it fake?

Almost certainly not. The redesigned pen starts with the plunger further down the cartridge, so the pocket of liquid you may remember is smaller or gone. Check the box seal, batch and expiry, and that the pharmacy is on the GPhC register. Contact the pharmacy if anything else looks wrong.

Does the new pen contain less medicine?

It contains less overfill. Each of the four doses is exactly the same as before. The only difference is what is left over afterwards.

Can I still use an older pen with liquid left after four doses?

The leaflet and Lilly say no: dispose of the pen after the fourth dose. The remaining liquid is not a measured dose and the pen is not tested to deliver it accurately.

Will my prescription or price change because of the new pen?

No. It is the same product, same strengths and same licence. The pen change does not alter Lilly’s list price, though pharmacies set their own retail prices and these move independently.

Sources

Monj is an independent price information service operated by Medstack Ltd. It does not sell, prescribe or supply medicines and does not give medical advice. Follow the instructions in your pen leaflet and from your prescriber. Report suspected side effects or suspected counterfeit medicines through the MHRA Yellow Card scheme.

Monj is an independent price comparison index operated by Medstack Ltd. We are not a pharmacy and we do not sell, prescribe, supply or dispense medicines. Listings are ranked strictly by the lowest total patient price, with alphabetical order used to break ties. No pharmacy can pay for placement, ranking or badges. Some outbound links earn a referral commission, and this never affects position or inclusion. Read the full independence statement.